Background. An increasing incidence of endemic hepatitis E (HE) has been reported in developed countries. Thus, an evaluation of the clinical characteristics of the disease and the utility of the current diagnostic methods is warranted.
Hepatitis E (HE) is one of the most common forms of hepatitis transmitted via the fecal-oral route worldwide. The causative agent of the disease, the hepatitis E virus (HEV), is classified in the genus Hepevirus, family Hepeviridae [1] . The Hepevirus genus also includes HEV strains that are capable of infecting other animal species such as avian hosts (chicken) [2] . Although only 1 serotype was described within the genus Hepevirus, 4 major genotypes with different modes of transmission, pathogenicity, reservoirs, and capacity for interspecies transmission were recognized in this genus [3] .
Although each HEV genotype is believed to have a specific geographic distribution, exceptions have been observed. Genotype 1 is mostly associated with epidemic or sporadic cases in the tropical and subtropical countries of Asia and Africa, whereas genotype 2 has been detected in Mexico and some African countries. The relative conservation of these 2 genotypes corresponds to their primary circulation among humans. Conversely, the diversity of the HEV genotypes 3 and 4 is related to their zoonotic potential. Genotype 3 has been isolated from patients with acute HE and from different animal species (in particular, domestic pigs, wild boar, and deer are the ones most likely to be involved in human transmission) worldwide. Genotype 4 contains human and animal strains originating particularly from Asian countries [4, 5] . Recently, genotype 4 was isolated from patients with endemic HE and domestic pigs in Europe [6, 7] .
HEV infection has at least 2 epidemiological profiles: large waterborne outbreaks and sporadic cases. The outbreaks are usually caused by genotype 1 or 2, and they result in high morbidity and mortality among pregnant women and young children in developing countries. The most common clinical presentation is acute icteric hepatitis, which is indistinguishable from other forms of viral hepatitis. HE attack rates peak among young to middle-aged adults (15-30 years) . Rates of infection are usually higher in men than in women; however, no sex difference exists in exposure to HEV. The sporadic cases of HE, which present clinically as icteric hepatitis or anicteric illnesses with nonspecific symptoms, are associated with genotypes 3 and 4 in both developing and industrialized countries. Endemic (autochthonous) HEV infections in developed countries, which are not related to travel in epidemic regions, have certain clinical features. Most patients are older (middle-aged and elderly people) and predominantly are men with an increased frequency of underlying liver disease or alcohol use. HEV can also cause neurological manifestations and chronic infection in immunocompromised persons, including those infected with the human immunodeficiency virus (HIV) [8, 9] . In contrast to epidemic HE, pregnant women do not show a severe course of endemic HEV infection. Nevertheless, sporadic HEV infections are associated with morbidity and mortality [10] [11] [12] .
Reports of HEV infections without travel association have become more frequent in nonhyperendemic regions (industrialized countries) in recent years [13] . According to the periodic reports of the National Institute of Public Health in Prague (Czech Central Database EPIDAT, http://www.szu.cz/publikace/ data/vybrane-infekcni-nemoci-v-cr-v-letech-2003-2012-absolutne), the numbers of imported cases of HE in the Czech Republic have remained stable during the last 2 decades, whereas a significant increase in the number of endemic HE cases has been observed (Figure 1 ) [14] . The disease is frequently recognized only by serological testing. Routine laboratory diagnostics for HE may be one reason for the observed increasing incidence. Almost all of the endemic HE cases are associated with genotype 3 or 4, and HEV isolates from patients show a high sequence homology to those found in domestic pigs and other animals [5, 15] .
Despite an increasing incidence, data regarding epidemiology and clinical manifestations of HEV infections in Central Europe are very limited. Therefore, the aim of the present study was characterization of acute hepatitis E cases hospitalized in a large referral center for infectious patients in Prague (Czech Republic), with a special attention to endemic cases of the disease. (Table 1) . Informed consent was obtained from all patients after obtaining approval from the local ethics committee (IRB00002721, Eticka komise Nemocnice Na Bulovce, IRB No. 1, Biomedical). The diagnosis of acute HE was established by the detection of anti-HEV antibodies, and positivity on enzyme-linked immunosorbent assay was confirmed by Western blotting. For patients 1-7, the EIAgen HEV IgM Kit, EIAgen HEV IgG Kit (both Adaltis, Italy), and Recomblot HEV IgM/IgG (Microgen GmbH, Germany) were used; for patients 8-51, the recomWell HEV IgM, recomWell HEV IgG, and recomLine HEV IgG/IgM (Microgen GmbH) were used. In addition, all patients tested negative for hepatitis A, B, and C virus infections, and the use of hepatotoxic drugs was ruled out.
PATIENTS AND METHODS

Fifty
We also evaluated the clinical, biochemical, hematological, and epidemiological parameters of the enrolled patients. Correlations between the biochemical and hemocoagulation examinations were tested using Spearman and Pearson correlations (Sigma Stat; Jandel Scientific, San Rafael, California).
The serum and stool samples originating from the enrolled patients were tested for the presence of the HEV genome (RNA) through the use of molecular methods. If possible, samples were collected at the beginning (stool and serum) and at the end (stool) of a patient's hospitalization. Detection of HEV RNA was performed by quantitative reverse transcription polymerase chain reaction (qRT-PCR) [16, 17] . Subsequently, the partial parts of the open reading frame (ORF) 1 and the overlapping region of ORFs 2 and 3 (ORF2/3) of the acquired HEV isolates were subjected to sequencing (Eurofins MWG Operon, Germany); sequence and phylogenetic analyses were performed using MEGA 3.1 software. The neighbor-joining method with 1000 replications in the bootstrap test was used [16, 17] .
RESULTS
HEV infection was serologically confirmed in 50 (98.0%) patients, and serum from 1 (2.0%) patient (number 5) was found to be anti-HEV immunoglobulin M (IgM) and immunoglobulin G (IgG) negative (Table 1) . Forty-eight patients with confirmed anti-HEV IgM and IgG positivity had acute symptomatic HE. Two of these patients (numbers 27 and 45) reported traveling to endemic regions (India and Thailand). Two patients (numbers 16 and 20) had asymptomatic courses of acute HE and were diagnosed by repeated serological testing because they had contact with a person with acute HE. In both patients, specific antibodies were detected. The first patient had mild hyperbilirubinemia, and the second patient had HEV RNA viremia and mildly elevated alanine aminotransferase (ALT). The patient (number 5) with acute endemic HE and negative serological examination was diagnosed by HEV RNA detection only; notably, this patient had a significant professional exposure (butcher). Demographic and clinical characteristics were evaluated in the group of 47 patients with symptomatic endemic HE: the ratio of men to women was 40:7; higher age was noted in both sexes (median, 61 years [range, 38-77 years]); the median duration of hospitalization was 14.69 days (SD, 9.21), with a range of 7-38 days. The laboratory parameters demonstrated a high level of total bilirubin; markedly elevated median levels of ALT, aspartate aminotransferase (AST), alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT); and no changes in median values of platelets, international normalized ratio (INR), or antithrombin III (AT III) ( Table 2 ). Significant correlations (P < .001) were found between total bilirubin and the following parameters: INR, AT III, and length of hospitalization (r = 0.472; r = −0.557; r = 0.469, respectively); the criteria for discharge from the hospital were total bilirubin <5.85 mg/dL, ALT 588.24 U/L, and normal coagulation parameters. Furthermore, correlations were found between HEV RNA loads in the stool and blood specimens collected after admission (r = 0.629; P = .002) and between the first and second stool samples (r = 0.970; P < .001). In addition, the following food exposures were recorded: a history of eating meat, innards (eg, porcine offal), or other food prepared during the domestic pig slaughter (eg, blood pudding, white pudding, head cheese, scraps, jellied sausage, liver, blood, and other sausages); tasting of raw meat before the cooking; and eating raw or inadequately cooked venison or boar meat (eg, wild boar goulash).
Only 1 patient (number 50, Table 1 ) with endemic HE progressed to acute liver failure. This 70-year-old man was admitted for acute hepatitis with underlying liver disease and alcohol abuse in his personal history. HEV infection was confirmed serologically (the anti-HEV IgM and IgG results were positive) and also by qRT-PCR. His liver and coagulation disorders gradually progressed, which necessitated a substitution of coagulation factors. A treatment with ribavirin (1200 mg/day) was introduced because liver transplant was contraindicated due to the patient's poor clinical condition and comorbidities. The patient died 10 days after admission due to bleeding in the gastrointestinal tract.
HEV RNA was detected in at least 1 sample of serum or stool originating from 43 (84.3%) patients; HEV RNA was not detected in the clinical samples originating from the 8 (15.7%) patients with acute HE. Overall, HEV RNA was detected in the stool samples from 39 of 51 (76.5%) patients, in the serum samples from 28 of 48 (58.3%) patients, and in both the stool and serum samples from 24 of 51 (47.1%) patients. In addition, the second stool samples collected prior to the end of hospitalization from 22 (43.1%) patients were tested for HEV RNA presence, and HEV excretion was found in 10 (45.5%) of these samples (Table 1) .
Subsequently, the sequences originating from HEV ORF1 and HEV ORF2/3 from 24 and 5 HEV isolates, respectively, were analyzed. The sequence and phylogenetic analyses demonstrated that 28 HEV isolates belonged to genotype 3; 1 HEV isolate belonging to genotype 1 was detected in 1 patient who had recently returned from India (Table 1, Figure 2) . Overall, genotype determination was possible in 29 of 43 (67.4%) patients with a positive HEV RNA detection. Partial sequences of ORF1 originating from 23 HEV isolates have been deposited in the GenBank database (Table 1) under accession numbers GU299812, GU299813, GU299815, and GU299817 ( patients 1, 2, 4, and 7) and from accession numbers KC924921 to KC924938 ( patients 8, 10, 15, 17, 18, 24, 26, 27, 30, 32, 33, 34, 35, 37, 38, 41, 42 , and 47).
DISCUSSION
The diagnosis of acute HE is usually based on the presence of anti-HEV IgM antibodies in serum and/or detection of HEV RNA in serum and/or in stool [18] . The high sensitivity of anti-HEV IgM antibodies was also apparent in our study; these antibodies were found in all but 1 patient with symptomatic acute HE. It is well known that >90% of patients infected with HEV have detectable anti-HEV IgM antibodies during the first 2 weeks after the onset of illness [19] . The serological appearance of anti-HEV IgM is followed shortly by anti-HEV IgG, and it seems that both antibodies appear almost simultaneously during the acute phase of the infection. Notably, anti-HEV IgM antibodies usually disappear during convalescence, whereas anti-HEV IgG antibodies may be detectable for up to 14 years [20] . As was already mentioned, the diagnosis of acute HEV infection can also be based on molecular methods, which allow direct detection of the causative agent (precisely, its genome). HEV RNA can be detected in serum and/or in stool samples of infected patients during the acute phase of the infection by RT-PCR using conventional and quantitative formats [21] . The detection of HEV RNA has the advantage of providing additional information about the viral load in the tested sample, and the additional sequencing of a specific portion of the viral genome allows for molecular epidemiological studies. On the other hand, the detection of HEV RNA has a limited value for the diagnosis of acute HEV infection due to usually brief periods of viremia (up to 2 weeks) and fecal shedding (up to 4 weeks) [22] . Nevertheless, our results indicate the frequent presence of fecal shedding of HEV and relatively frequent viremia during acute HE infection.
The clinical features of HE are similar to those of acute viral hepatitis caused by other hepatotropic viruses, but some differences exist. In our group of 47 patients with clinically symptomatic endemic acute HE, the patients were significantly older, with a clear prevalence of men. The patients' liver function tests revealed the prevalence of icteric forms of hepatitis, sometimes with very high levels of total bilirubin (the highest value was 35.92 mg/dL), very often with markedly elevated serum levels of ALT, AST, ALP, and GGT and without any dilation of bile ducts on ultrasonography (data not shown). The process of the normalization of patients' hyperbilirubinemia and liver function tests was frequently protracted, which led to relatively long hospital stays. Although clinically expressed hemocoagulation disorders were very rare in our cohort, some patients had significantly prolonged INR and decreased AT III levels. Prolonged INR and high bilirubin levels are well-known predictors of the severity of viral hepatitis; however, less is known about AT III levels in patients with acute hepatitis. The decreased AT III levels have already been observed in severe shock and some other serious infections, but their importance in viral hepatitis has not yet been established [23, 24] . Thus, it is of interest that the low AT III levels were associated with a longer hospital stay and that the lowest AT III level was found in the patient (number 50) who progressed to acute liver failure with a fatal outcome ( Table 1) . Several factors have been reported as being potentially associated with acute liver failure or a fatal outcome of acute endemic HE, including presenting or underlying chronic liver disease or being infected with HEV of genotype 4 or 1 [25] [26] [27] . Substantially fewer cases of fatal fulminant hepatitis have been described following genotype 3 HEV infections [28, 29] . We assume that the fatal outcome of our patient was due to an underlying chronic alcoholic liver disease. Unfortunately, the fatal outcome of the patient was not reversible, even after treatment with ribavirin, which was previously reported to be highly effective in treating chronic and acute HEV infections [30] [31] [32] .
The diagnosis of acute HE can also be established in patients after contact with HE using repeated serological examinations. Only 2 such patients were detected in our group of 51 patients (Table 1) . This number indicates a low contagiousness of the patients with acute HE caused by genotype 3 even with their close contacts. In developed countries, anti-HEV antibody prevalence rates ranging from 1% to >20% have been reported; this rate may reflect exposure to HEV-infected animals or their excrement, asymptomatic HEV infection, serologic cross-reactivity with other causal agents, and/or false-positive serologic testing. It was also demonstrated that veterinarians and farmers coming in close contact with pigs have higher anti-HEV seroprevalence rates than the general population [33] . Moreover, the data from the Czech Central Database EPIDAT show a significantly increased number of endemic cases compared to imported HE cases in the Czech Republic in the last 2 decades (Figure 1 ) [14] . This trend is partly due to increased awareness of HE among physicians, resulting in more extensive serologic testing of patients with a suspicion of hepatitis. However, negative epidemiological trends with an increased incidence of transmission of HEV from animals to humans cannot be ruled out.
The source of HEV infection remains unidentified in the majority of HE cases, but the gathering evidence suggests zoonotic transmission of HEV infection: Consumption of raw or not properly heat-treated meat, porcine offal during the pig home slaughter, tasting of raw meat products before cooking, and cross-contamination with blood or meat juice were the most frequent epidemiological data obtained from our patients ( Table 1 ). The possible zoonotic origin of HEV infection was also suggested by sequence and phylogenetic analyses of human and animal HEV strains in the Czech Republic. The zoonotic genotype 3 was detected in 28 (96.6%) of the sequenced HEV isolates; in addition, high phylogenetic relatedness was observed between the present human and animal HEV isolates originating from Czech domestic pigs and wild boars ( Figure 2 ). It is worth noting that although the main route of HEV genotype 3 transmission is most likely zoonotic transmission, rare cases of transfusion-associated infections have also been reported [34, 35] .
Our study has certain limitations. First, the patients with acute HE were enrolled at a single center. However, this center has a catchment area of 2 million inhabitants, which represents one-fifth of the entire Czech population. Second, the laboratory diagnostics of HEV infection were not standardized and there is a risk of false-negative or false-positive results. Thus, the positive results of serology testing should be confirmed by Western blotting, which has been a standard approach introduced in our institution since the beginning of the study period. Third, sequencing and following the sequence and phylogenetic analyses of the detected HEV genome was not possible in all of the Endemic Hepatitis E • CID 2014:58 (15 February) • 515 patients with HEV infection enrolled in the study. Based on previous studies, sequencing is successful only when the viral load in the tested sample is >10 2 of genomic equivalents, which allowed for the determination of the HEV genotype in more than half of enrolled patients.
In conclusion, our results demonstrated specific clinical, laboratory, and epidemiologic characteristics of patients with acute endemic HE. The knowledge of these findings, together with the routine use of a combination of serologic and molecular methods, may improve the diagnostic process of HE. Moreover, the use of molecular methods may help in our understanding of the zoonotic potential of HEV and process of its transmission to humans.
